Symposium 4: Approaches to assess medication exposureand associated risks during pregnancy using Real-World
DataModerators
Kenneth Man, University College London, UK; University of Hong Kong, Hong Kong
Kenneth is currently a Maplethorpe Fellow at the Research Departmentof Practice and Policy, UCL School of Pharmacy, London. He is also
current chair of Asia Pharmacoepidemiology Network (AsPEN), a
collaborative network on medication safety and pharmacoepidemiology
research across the Asia-Pacific region. With expertise in medication
research with electronic health care databases and novel epidemiologicalmethodologies, his work encompassed research in Paediatric andPsychiatric Pharmacoepidemiology in particular treatment forneurodevelopmental disorders. He receives the CW Maplethorpe
Fellowship in Pharmacy to investigate the safety of psychotropic medications use inpregnancy.
Keiko Asao, Amgen Astellas BioPharma K.K., Japan
Keiko Asao is an epidemiologist by training and is currently working at
Amgen Astellas BioPharma K.K. (AABP) as the lead of Observational
Research group in Japan. She has been working toward establishing
applications of real-world data use in drug development throughout
lifecycle. She has been involved in various epidemiological studies andhealth outcomes research while practicing medicine at academic
institutions in Japan and in the United States. Prior to joining
AABP, she was a medical advisor at Eli Lilly Japan, K.K.

Speakers
Jeff Lange, Amgen Inc., USA
Jeff is an epidemiologist within Amgen’s Center for Observational
Research. He received his PhD from the University of Iowa. During his 8years at Amgen, he has been applying the use of observational researchfor both clinical development and regulatory decision-making within thetherapeutic areas of oncology and general medicine. Currently, Jeff is
supporting further development of organizational capabilities within Asia.

Kenneth Man, University College London, UK; University of Hong Kong, Hong Kong
Kenneth is currently a Maplethorpe Fellow at the Research Departmentof Practice and Policy, UCL School of Pharmacy, London. He is also
current chair of Asia Pharmacoepidemiology Network (AsPEN), a
collaborative network on medication safety and pharmacoepidemiology
research across the Asia-Pacific region. With expertise in medication
research with electronic health care databases and novel epidemiologicalmethodologies, his work encompassed research in Paediatric andPsychiatric Pharmacoepidemiology in particular treatment forneurodevelopmental disorders. He receives the CW Maplethorpe
Fellowship in Pharmacy to investigate the safety of psychotropic medications use inpregnancy.
Maki Ueyama, Creativ-Ceutical K.K., Japan
Maki is a Consultant for Creativ-Ceutical in Japan. She holds a MPA,
M.S., and Ph.D. in Policy Analysis and Management from Cornell
University. She is an economist with training and experience in healtheconomics, econometrics, public health, and policy. Prior to joining
Creativ-Ceutical, she held various research positions including a leadevaluator in a provincial heath authority and a fellow in an academic
research institution in Canada. She is currently involved in several realworld database projects, including analyses using a claims databasein Japan.
Tomofumi Ishikawa, Tohoku University, JapanDr. Tomofumi Ishikawa is a Research Collaborator at Tohoku University
Graduate School of Pharmaceutical Sciences and an employee of Pfizer
R&D Japan. He received his PhD in Tohoku University Graduate Schoolof Pharmaceutical Sciences. He is a registered pharmacist in Japan.
He has worked for Pfizer and been responsible for drug development for
more than 10 years. Concurrently, he has been a member of theLaboratory of Clinical Pharmacy, Tohoku University Graduate School of
Pharmaceutical Sciences since 2016. He has engaged inpharmacoepidemiological research there and especially focused on
perinatal medication use using a large administrative database.